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Abstract
Background: The purpose of this study was to identify demographic, clinical, psychosocial, physical and
environmental factors that are associated with participation in and adherence to a combined resistance and
endurance exercise program among cancer survivors, shortly after completion of primary cancer treatment. Data from
the randomized controlled Resistance and Endurance exercise After ChemoTherapy (REACT) study were used for this study.
Methods: The participants of the REACT study were randomly allocated to either a high intensity (HI) or low-
to-moderate intensity (LMI) exercise program. Patients’ participation rate was defined as the cancer survivors’
decision to participate in the REACT study. Exercise adherence reflected participants’ attendance to the scheduled
exercise sessions and their compliance to the prescribed exercises. High session attendance rates were defined as
attending at least 80 % of the sessions. High compliance rates were defined as performing at least of 90 % of the
prescribed exercise across all sessions. Correlates of exercise adherence were studied separately for HI and LMI
exercise. Demographic, clinical, and physical factors were assessed using self-reported questionnaires. Relevant
clinical information was extracted from medical records. Multivariable logistic regression analyses were applied to
identify correlates that were significantly associated with participation, high session attendance, high compliance
with resistance and high compliance with endurance exercises.
Results: Participants were more likely to have higher education, be non-smokers, have lower psychological distress,
higher outcome expectations, and perceive more exercise barriers than non-participants. In HI exercise, higher
self-efficacy was significantly associated with high session attendance and high compliance with endurance
exercises, and lower psychological distress was significantly associated with high compliance with resistance
exercises. In LMI exercise, being a non-smoker was significantly associated with high compliance with resistance
exercises and higher BMI was significantly associated with high compliance with resistance and endurance
exercises. Furthermore, breast cancer survivors were less likely to report high compliance with resistance and
endurance exercises in LMI exercise compared to survivors of other types of cancer. The discriminative ability
of the multivariable models ranged from 0.62 to 0.75.
Conclusion: Several demographic, clinical and psychosocial factors were associated with participation in and
adherence to exercise among cancer survivors. Psychosocial factors were more strongly associated with adherence in
HI than LMI exercise.
Trial registration: This study was registered at the Netherlands Trial Register [NTR2153] on the 5th of January 2010.
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Background
Supervised exercise programs following cancer diagnosis
show significant and clinically relevant beneficial effects
on cardiorespiratory fitness [1], general and physical fatigue
[2] and quality of life (QoL) [3]. More specifically, exercise
can improve cancer survivors’ cardiorespiratory fitness,
thereby reducing fatigue and improve global QoL and
physical function [4]. In addition, observational studies have
reported positive associations of physical activity [5] and
fitness [6] with cancer-free and overall survival, yet, ran-
domized controlled trials (RCTs) need to establish causality.
The success of RCTs evaluating exercise programs de-
pends largely on patients’ participation and exercise ad-
herence rates. Patients’ participation rate reflects the
decision by cancer survivors whether or not to partici-
pate in a randomized controlled trial evaluating exercise
interventions. Exercise adherence reflects participants’ ses-
sion attendance rates and their compliance to the pre-
scribed exercises. A better understanding of the modifiable
and unmodifiable correlates that are associated with par-
ticipation in and adherence to exercise interventions
may inform future interventions and facilitate success-
ful implementation of exercise programs among cancer
survivors. Modifiable correlates (e.g., psychosocial) pro-
vide insights into intervention target components via
which improvements in participation or adherence might
be achieved. Unmodifiable correlates, such as demo-
graphics (e.g., age) or clinical variables (e.g., treatment
type) indicate which subgroups of patients are most at
risk for non-participation or low exercise adherence
rates and can thus help to identify relevant target popu-
lations for intervention.
Correlates of participation in exercise trials during pri-
mary cancer treatment have been investigated by two
previous trials [7, 8] and both studies reported that par-
ticipants who perceived higher levels of fatigue were less
likely to participate in the exercise trials. Furthermore,
minimizing practical barriers to participation such as travel
distances to practices and flexible training schedules were
suggested as promising strategies to enhance participa-
tion in forthcoming studies [7, 8]. However, correlates
of participation in exercise trials after completion of
primary cancer treatment have not been studied yet, and
may differ from those during primary cancer treatment.
In a recent systematic review, we identified correlates
of exercise adherence among cancer survivors [9], and
found exercise history to be significantly associated with
exercise adherence. Other important demographic, clin-
ical, psychosocial and environmental correlates of exercise
adherence could not be distinguished due to the limited
number of studies, or the inconsistency of findings across
the reviewed manuscripts. Moreover, the definition of
exercise adherence varied across the reviewed studies.
Some studies exclusively focused on session attendance
rate, while other studies also incorporated a measure
on compliance. Therefore, more research is warranted.
The current study aimed to identify demographic, clin-
ical, psychosocial, physical and environmental factors
that are associated with participation in an exercise pro-
gram and exercise adherence among cancer survivors,
shortly after completion of primary cancer treatment. We
used data of the Resistance and Endurance exercise After
ChemoTherapy (REACT) study [10], a RCT that evalu-
ated the effectiveness of a high intensity (HI) and low-to-
moderate intensity (LMI) exercise compared to a waiting
list control (WLC) group shortly after completion of
primary cancer treatment on physical fitness, fatigue
and health-related quality of life (HRQoL). We found
that HI and LMI exercise significantly improved cardio-
vascular fitness, reduced fatigue and improved quality
of life [11].
Methods
Detailed procedures of the REACT study have been re-
ported elsewhere [11]. Briefly, the REACT study was a
multicenter RCT in which 277 cancer survivors were
randomized into three study arms: HI exercise, LMI ex-
ercise, and a WLC group. Between 2011 and 2013, pa-
tients were recruited from 9 hospitals in the Netherlands.
Patients aged ≥ 18 years with histologically confirmed
breast, colon, ovarian, cervix or testis cancer, or lymph-
omas with no indication of recurrent or progressive dis-
ease, who had completed ((neo-) adjuvant) chemotherapy
were eligible. Patients were excluded if they were unable to
perform basic physical activity, had cognitive disorders, se-
vere emotional instability, comorbidities that might ham-
per capacity of carrying out HI exercise, or were unable to
understand and read the Dutch language. This study was
approved by the Medical Ethics Committee of the VU
University Medical Centre [2011/240] and the local eth-
ical boards of all participating hospitals.
(Non-)participation
Patients who were willing to participate were invited for
baseline measurements, 4–6 weeks after completion of
primary cancer treatment. After baseline measurements,
participants were stratified by cancer type and hospital,
and randomly assigned to one of the three study arms. HI
and LMI groups started with their 12-weeks exercise pro-
gram directly after randomization (i.e., direct start). Partic-
ipants from the WLC group were also randomly allocated
to HI or LMI exercise. However, they started exercising
12 weeks later. Patients who chose not to participate (i.e.,
non-participants) were invited to complete a one-time
survey that was similar in content and timing to the base-
line questionnaire of the REACT participants. Written in-
formed consent was obtained from both non-participants
and participants, including permission to extract relevant
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information from their medical records. Finally, from
patients who chose to refrain from any participation, only
age, gender and cancer type were documented.
Exercise interventions
Full details of the 12-week HI and LMI programs have
been described previously [10]. In short, both interven-
tions included two one-hour supervised resistance and
endurance exercise sessions per week and were identical
with respect to exercise frequency, type, and duration,
and differed only in exercise intensity (Table 1). Both ex-
ercise programs included six resistance exercises target-
ing large muscle groups with a frequency of two sets of
ten repetitions. Workload per exercise was defined by an
indirect one repetition maximum (1-RM) measurement.
Furthermore, both programs included two types of endur-
ance interval exercises, aiming to maximize improvements
in cardiorespiratory fitness. In the first four weeks patients
cycled 2x8 min with alternating workloads. Workloads
were defined by the maximum short exercise capacity
(MSEC) estimated by the steep ramp test. From the fifth
week onwards, one additional endurance interval session
was added, substituting eight minutes of cycling. This
interval session consisted of three times five minutes
cycling at a constant workload. Here, the workload was de-
fined by the heart rate reserve (HRR), using the Karvonen
formula. Twenty-one local physiotherapists supervised all
training sessions. In the Netherlands, people are generally
used to short travel distances to their health care providers
and therefore patients trained at local physiotherapists
practices close to the patients’ homes. The availability of
flexible training hours and the possibility to join a re-
habilitation group differed per practice. Furthermore,
the start of the exercise programs was linked to the time
point of completion of the primary cancer treatment of
the individual cancer survivor. Consequently, the training
hours and the availability of group sessions varied.
Adherence
Adherence was defined as attendance to the prescribed
number of sessions and compliance with the prescribed
intensity, frequency and duration of the prescribed resist-
ance and endurance exercises [12, 13]. Both session at-
tendance rates and compliance rates were retrieved from
exercise logs completed by the physiotherapists. Session
attendance was defined as the number of supervised exer-
cise sessions attended, divided by the number of super-
vised exercise sessions offered. Compliance with resistance
exercises was defined in terms of intensity and volume
(Table 2), in which compliance with the intensity of the
resistance exercises was calculated by the performed
training load, divided by the prescribed training load
and compliance with the volume of the resistance exer-
cises was calculated by the performed number of repe-
titions, divided by the prescribed number of repetitions.
The average value of compliance with intensity and vol-
ume provided the overall measure for compliance with
the resistance exercises. Compliance with endurance exer-
cises was defined as exercise duration (in minutes), divided
by the prescribed exercise duration (Table 2). The average
of this parameter provided the overall measure for compli-
ance with the endurance exercises. Next, the normality
assumption was tested for session attendance, compliance
with resistance training, and compliance with endurance
training. Since they were skewed, and to facilitate clinic-
ally meaningful interpretation, we dichotomized adher-
ence outcome variables based on clinically-relevant cut-off
points. In line with previous studies, high session attend-
ance was defined as attending at least 80 % of the sessions
[14]. We defined high compliance rates as performing at
least 90 % of the resistance and endurance exercises
according to the prescribed dosage. This cut-off point
of 90 % allowed some deviation due to the rounded
weights and settings of the local training equipment,
while maintaining a sufficient distinction between HI
and LMI exercise.
Assessment of correlates
Demographic data were collected using a self-report
questionnaire and included age at baseline (in years),
gender (0 =male; 1 = female), marital status (0 = no partner;
1 =married or de facto), education (0 = low/intermediate;
Table 1 Exercise intensities of the HI and LMI resistance and endurance exercise programs
Resistance exercises (1-RM)a
(10 repetitions in 2 series
of 6 exercises targeting the
large muscle groups)
Endurance interval exercises
Part A (MSEC)a
(8 min alternating workload)
Endurance interval exercises
Part B (HRR)a
(3x5 min constant workload)
Counseling
High intensity (HI)
exerciseb
70-85 % 30/65 % ≥80 % Participants were encouraged
to start or maintain a physically
active lifestyle in addition to
the supervised exercise sessions.Low-to-moderate intensity
(LMI) exerciseb
40-55 % 30/45 % 40-50 %
Abbreviations: 1-RM one repetition maximum, MSEC maximum short exercise capacity, HRR heart rate reserve, HI high intensity exercise, LMI low-to-moderate
intensity exercise
aEvery four weeks (week 1, 5 and 9), the physiotherapist evaluated training progress, and adjusted the workload accordingly. bExercises were accompanied with
BORG scores and heart rate monitors to guide the physiotherapists. In the occasion that the training intensity seemed too high or too low, the 1-RM, MSEC or
HRR were reassessed
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1 = high), employment status (0 = no paid employment;
1 = paid employment), smoking status (0 = non-smoker;
1 = smoker) and sport history (0 = no; 1 = yes). Further-
more, participants’ travel distance to the exercise pro-
gram (in kilometres) was calculated based on zip codes
of the patient’s home and location of training facility.
Clinical information was retrieved from medical records
and included cancer type (0 = breast cancer; 1 = other (i.e.,
colon, ovarian, cervix or testis cancer, or lymphomas)),
stage of disease (0 = stage I-II, 1 = stage III-IV), previous
treatment with surgery (0 = no; 1 = yes), radiation therapy
(0 = no; 1 = yes), immunotherapy (0 = no; 1 = yes), hor-
mone therapy (0 = no; 1 = yes), and two or more of the
following comorbidities (0 = no; 1 = yes) including heart
disease, lung disease, diseases of the digestive system,
diseases of the nervous system, endocrine disease, men-
tal disorder, rheumatism or arthritis, or chronic pain
[15]. In addition, body weight of the REACT partici-
pants was measured to the nearest 0.1 kg on a digital
scale, with light clothes on and no shoes. Body height was
measured to the nearest 0.1 cm without shoes. Body mass
index (BMI) was calculated from the measured body
weight and height accordingly.
Patient-reported outcomes have been reported else-
where [16] and included general fatigue (subscale of the
Multidimensional Fatigue Inventory (MFI) [17]), global
quality of life (subscale of the European Organisation Re-
search and Treatment of Cancer - Quality of Life Ques-
tionnaire C30 (EORTC QLQ C-30) [18]), psychological
distress (Hospital Anxiety and Depression Scale (HADS)
[19]) and self-reported physical activity using the Physical
Activity Scale for the Elderly questionnaire (PASE) [20].
Patient-reported behavioral and attitudinal factors to-
wards exercise included a series of questions that were
based on health behavior theories, in particular the Theory
of Planned Behavior [21]. Current attitude towards exer-
cise participation was measured by one item ‘In my opin-
ion regular exercise is..’ rated on 5-point Likert scale (1 =
very bad to 5 = very good) [21]. Barriers to exercise behav-
ior (Cronbach’s α = 0.85) were measured using 18 items
(e.g., my disease, insufficient motivation, lack of energy),
rated on 5-point Likert scale (1 = never to 5 = very often)
[21, 22]. Outcome expectations regarding exercise par-
ticipation (Cronbach’s α = 0.91) included 12 items (e.g.,
increase my health, feel better about myself, and be
more physically fit), rated on a 5-point Likert scale (1 =
strongly disagree to 5 = strongly agree) [21, 22]. Exercise
self-efficacy (Cronbach’s α = 0.83) was assessed with the
following question ‘How confident are you that you will
be physically active in the following situations’, including
feeling tired, bad mood, do not have the time, on vacation,
and, want to be active outside, but bad weather, rated on a
10-point Likert scale (1 = absolutely no confidence, 10 =
completely confident) [23]. Social support for exercise
(Cronbach’s α = 0.92) was assessed using the statement:
‘The following people are supportive of my regular PA’,
followed by: family, friends, and other cancer patients,
rated on a 5-point Likert scale (1 = strongly disagree to
5 = strongly agree) [24]. Mean scores were calculated
for potential correlates that comprised more than one
item. After that, all factors were linearly transformed to
a 0-100 scale. Exercise stage was measured using the
response options derived from the Transtheoretical
Model [25]: (1) no intention to exercise; (2) intention
to exercise; (3) irregular exercise; (4) started exercising
30 min a day in last 6 months; or (5) exercising 30 min
a day for longer than 6 months, that were dichotomized
into non-exerciser (response options 1–3) and exerciser
(response options 4–5).
Statistical analyses
The statistical analyses were performed using IBM SPSS
Statistics (SPSS Inc., Evanston, IL, version 22.0). Descriptive
statistics (mean and standard deviations (SD)) were calcu-
lated for all outcome variables. Data on BMI and travel
distance to the exercise program for the non-participants
were not available due to trial logistics. Correlations be-
tween all potential correlates were checked for multicolli-
nearity (r ≥ 0.60). Multicollinearity was present between
cancer type and gender. Because cancer type was most
strongly associated with exercise adherence, this variable
was included in the model instead of gender. Differences
in session attendance rates and compliance rates between
HI and LMI exercise were tested using chi-square tests.
To examine whether correlates of exercise adherence
differed between HI and LMI exercise groups, we added
an interaction term of the correlate with the interventions
into a regression model, separately for each correlate. As
significant interaction terms were found for education,
cancer type, self-efficacy, and psychological distress, we
performed stratified analyses for HI and LMI. All analyses
on exercise adherence were performed according to an
intention-to-treat principle.
Univariable and multivariable logistic regression analyses
were conducted to identify factors that were significantly
correlated with participation and exercise adherence.
Separate multivariable logistic regression analyses with
a forward selection procedure were carried out for each
Table 2 Outcome measures of compliance to the prescribed
exercises
Compliance
Resistance exercises Endurance interval
exercises
Intensity Volume Duration
Used loada
Prescribed load  100% Performed repetitionsPrescribed repetitions 100% Performed duration
b
Prescribed duration  100%
aLoad in kilograms, btime in minutes
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outcome variable: participation, high session attendance
and high compliance with the resistance and endurance
exercises. By default, timing of intervention (i.e., direct
start or WLC group) was retained as covariate in the
univariable and multivariable models of exercise adher-
ence. First the independent variables with a p-value ≤0.25
in the univariable analyses were selected for further ana-
lyses. After that, a multivariable stepwise forward selection
procedure was undertaken by identifying the correlates
that was most strongly associated with the dependent
variable. Subsequently, the next strongest related correlate
was then selected after controlling for the first correlate.
Only variables with a p-value of ≤0.05 were retained in the
final multivariable model. The regression coefficients (β)
and odds ratio (OR) with 95 % CI were reported accord-
ingly. In addition, the model fit was evaluated by the area
under the receiver operating characteristic curve (AUC)
with 95 % CI.
Results
In total, 277 out of 757 eligible patients (37 %) partici-
pated. Furthermore, 179 patients (24 %) did not participate
in the trial, but completed the one-time survey (i.e., non-
participants). Self-reported reasons for non-participation
were having too many things on one’s mind (n = 72),
already exercising (n = 30), not wanting to be random-
ized (n = 20), and not interested to participate in a clin-
ical trial (n = 13). For 44 non-participants the reason of
non-participation was unknown. Baseline demographic,
clinical, psychosocial and physical characteristics of the
participants and non-participants are presented in Table 3.
90 % of the participants and non-participants underwent
surgery to treat cancer, revealing very little variability
within our population. Therefore, we omitted surgery
as a potential correlate for participation and exercise
adherence from the multivariable regression analyses.
High session attendance was found in 76 % and 67 %
of the participants in HI and LMI groups respectively
(p = 0.10). High compliance with resistance exercises was
found in 69 % of the participants in HI and in 67 % of par-
ticipants in LMI (p = 0.80). High compliance with endur-
ance exercises was found in 47 % of the participants in HI
and in 42 % of the participants in LMI (p = 0.40).
Correlates of participation
The results of the univariable and multivariable logistic
regression analyses are presented in Table 4. The multi-
variable regression model showed that participants were
more likely to have higher education, (OR = 1.79, 95 % CI:
1.14; 2.82), non-smoking habits (OR = 0.46, 95 % CI: 0.23;
0.92), lower psychological distress (OR = 0.94, 95 % CI:
0.91; 0.98), higher outcome expectations (OR = 1.02, 95 %
CI: 1.01; 1.04), and perceive more exercise barriers (OR =
1.05, 95 % CI: 1.03; 1.07) than non-participants. The AUC
for this model was 0.69 (95 % CI: 0.64; 0.74). No signifi-
cant associations were found between participation and
treatment-related or physical characteristics.
Correlates of adherence in HI
In HI, higher self-efficacy was significantly associated
with high session attendance (OR = 1.06, 95 % CI: 1.03;
1.09; AUC = 0.75, 95 % CI: 0.66; 0.84) and high compli-
ance with endurance exercises (OR = 1.05, 95 % CI: 1.02;
1.07; AUC = 0.68, 95 % CI: 0.59; 0.77) (Table 5). Further-
more, less psychological distress (OR = 0.87, 95 % CI: 0.81;
0.94) was significantly correlated with high compliance
with resistance exercises in HI (AUC= 0.69, 95 % CI: 0.60;
0.79). Demographic, treatment-related, physical and envir-
onmental characteristics were not significantly associated
with exercise adherence in HI.
Correlates of adherence in LMI
In LMI, being a non-smoker (OR = 0.16, 95 % CI: 0.03;
0.91) was significantly associated with high compliance
with resistance exercises (Table 5), and higher BMI was
significantly associated with high compliance with resistance
exercises (OR = 1.11, 95 % CI: 1.00; 1.23) and endurance ex-
ercises (OR = 1.11, 95 % CI: 1.01; 1.21). Furthermore, breast
cancer survivors were less likely to report high compliance
with resistance exercises (OR = 3.25, 95 % CI: 1.31; 8.02)
and high compliance with endurance exercises (OR = 2.94,
95 % CI: 1.38; 6.27) in LMI than survivors of other types of
cancer. The AUC for the models of high compliance with
resistance and endurance exercises were 0.69 (95 % CI:
0.60; 0.79) and 0.67 (95 % CI: 0.58; 0.77), respectively.
Treatment-related, psychosocial, physical and environ-
mental characteristics were not significantly associated
with exercise adherence in LMI.
Discussion
The current study identified important demographic, clin-
ical, psychosocial, physical and environmental factors that
may influence participation and exercise adherence, aim-
ing to facilitate successful exercise participation among
cancer survivors. We found that some demographic and
psychosocial factors were significantly associated with
exercise participation and adherence. Additionally, we
found that psychosocial factors such as psychological
distress and self-efficacy were more strongly associated
with adherence to HI than LMI.
(Non-) participation
The current participation rates of 37 % are in line with
previous exercise trials among cancer survivors, reporting
that 35–50 % of the eligible patients participated [26, 27].
Our finding that patients with a high level of education
were more likely to participate supports previous findings
in cancer survivors during active cancer treatment [8].
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Table 3 Baseline characteristics of (non-) participants
Non-participants (n = 179) Participants (n = 277)
HI (n = 139) LMI (n = 138)
Demographic
Age, mean (SD) years 55 (10.6) 54 (10.7) 53 (11.4)
Gender, n (%) male 26 (15) 29 (21) 26 (19)
Marital status, n (%) having a partner 150 (84) 112 (81) 120 (87)
Education, n (%) high 43 (25) 52 (38) 53 (39)
Employment status at baseline, n (%) yes 91 (51) 85 (61) 82 (59)
Smoking status at baseline, n (%) yes 27 (15) 9 (7) 8 (6)
Sport history, n (%) yes 100 (57) 72 (52) 83 (61)
Clinical
Cancer type, n (%)
Breast 120 (67) 92 (66) 89 (65)
Colon 31 (17) 25 (18) 24 (17)
Ovarian 6 (3) 8 (6) 4 (3)
Lymphoma 16 (9) 10 (7) 16 (12)
Cervix 4 (2) 0 4 (3)
Testis 2 (1) 4 (3) 1 (1)
Stage of disease, n (%)
Local 123 (69) 103 (74) 84 (61)
Advanced 55 (31) 36 (26) 54 (39)
Type of treatment, n (%)
Surgery 161 (90) 127 (91) 123 (89)
Radiation therapy 87 (49) 74 (53) 61 (44)
Immunotherapy 33 (18) 23 (17) 36 (26)
Hormone therapy 81 (45) 67 (48) 61 (44)
Comorbidities ≥2, n (%) yes 26 (15) 16 (12) 14 (10)
BMI in kg/m2, mean (SD) n.a. 27.2 (4.5) 26.6 (4.2)
Psychosocial
General fatigue (MFI), mean (SD)a 12.3 (4.4) 12.8 (3.8) 12.9 (4.2)
Global HRQoL (QLQ-C30), mean (SD)b 70.9 (18.2) 71.3 (16.2) 73.1 (16.1)
Psychological distress (HADS), mean (SD)c 8.2 (6.4) 7.4 (5.7) 7.6 (5.3)
Attitude, mean (SD) 83.8 (21.2) 85.2 (22.3) 87.3 (18.8)
Perceived barriers, mean (SD) 23.1 (12.4) 28.6 (12.3) 25.8 (12.0)
Outcome expectations, mean (SD) 71.8 (17.8) 75.0 (15.7) 76.0 (13.7)
Self-efficacy, mean (SD) 64.8 (17.9) 59.9 (16.6) 61.1 (16.4)
Social support, mean (SD) 79.3 (21.1) 81.9 (20.6) 81.0 (20.1)
Physical
Exercise stage, n (%)d 85 (50) 66 (49) 67 (49)
Self-reported PA 115.6 (91.3) 96.7 (69.0) 106.2 (83.1)
Environmental
Travel distance to the exercise program (in kilometres), mean (SD) n.a. 7.3 (6.1) 6.5 (4.8)
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Accordingly, it has repeatedly been found in non-clinical
populations that people who attained higher education are
more likely to participate in health behavior change inter-
ventions [28]. Furthermore, the current study identified
non-smoking as a significant correlate of participation.
This was in contrast with a study in the Netherlands, who
found no significant association between smoking and
participation in an exercise trial during cancer treatment.
Possibly, cancer survivors who chose to participate in an
exercise trial after completion of primary cancer treatment
might have experienced a ‘teachable moment’, or a need
to change, during cancer treatment, including quitting
smoking and participating in an exercise program [29]. Fi-
nally, we found that lower psychological distress, higher
outcome expectations and experiencing more exercise
barriers were significantly associated with participation.
Our findings that patients with higher psychological dis-
tress and lower outcome expectations were more likely to
decline participation, is in line with the previous study
evaluating exercise programs in breast cancer survivors
during chemotherapy [8]. Aiming to successfully target
those subgroups of patients, previous studies suggested
that clinical practice may benefit from behavior change
strategies such as motivational interviewing [30]. Yet, fur-
ther evidence is needed to determine which approaches
are most efficacious among cancer survivors. Our finding
that REACT participants reported more exercise barriers
than non-participants seems paradoxical. However, it is
possible that non-participants were not interested in exer-
cise shortly after completion of primary cancer treatment
and consequently perceived fewer barriers to obtain and
maintain exercise, or that participants were more open to
support from healthcare professionals in overcoming their
exercise barriers, compared to the non-participants.
Adherence
In the HI and LMI groups, 76 % and 67 % of the partici-
pants showed high attendance rates, which is within the
range reported by other exercise trials following cancer
diagnosis [9]. However, comparing studies is limited by
the scarcity of studies reporting on session attendance
rates to supervised exercise after primary cancer treatment
[9]. The compliance rates with the resistance and
Table 3 Baseline characteristics of (non-) participants (Continued)
Adherence
High session attendance, n (%) - 106 (76) 93 (67)
High compliance with resistance exercises, n (%) - 93 (69) 87 (67)
High compliance with endurance exercises, n (%) - 64 (47) 55 (42)
Abbreviations: SD standard deviation, n number, HI high intensity exercise, LMI low-to-moderate intensity exercise, BMI body mass index, n.a. not applicable,
PA physical activity
aRange 4-20, higher score means a higher level of self-reported general fatigue; bRange 0-100, higher score means a higher level of self-reported global HRQoL;
cRange 0-36, higher means a higher level of anxiety and/or depression; dcurrently exercising
Table 4 Odds ratios and their 95 % confidence intervals as
results from univariable and multivariable logistic regression
analyses with participation as dependent variable and
demographic, clinical, psychosocial and physical variables as
independent variables
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Demographic
Age 0.99 (0.97;1.00)
Gender 0.69 (0.41;1.14)
Marital status 1.00 (0.60;1.66)
Education 1.89 (1.24;2.89) 1.79 (1.14;2.82)
Employment status 1.47 (1.01;2.15)
Smoking status 0.37 (0.19;0.70) 0.46 (0.23;0.92)
Sport history 0.99 (0.67;1.44)
Clinical
Cancer type 1.08 (0.73;1.61)
Stage of disease 1.08 (0.72;1.61)
Type of treatment
Radiation therapy 1.01 (0.69;1.46)
Immunotherapy 1.20 (0.75;1.93)
Hormone therapy 1.04 (0.71;1.52)
Comorbidities (≥2) 0.72 (0.41;1.25)
Psychosocial
General fatigue 1.03 (0.99;1.08)
Global HRQoL 1.01 (0.99;1.02)
Psychological distress 0.98 (0.95;1.01) 0.94 (0.91;0.98)
Attitude 1.01 (1.00;1.02)
Perceived barriers 1.03 (1.01;1.05) 1.05 (1.03;1.07)
Outcome expectations 1.02 (1.00;1.03) 1.02 (1.01;1.04)
Self-efficacy 0.99 (0.97;1.00)
Social support 1.01 (1.00;1.01)
Physical
Exercise stage 0.97 (0.66;1.42)
Self-reported PA 1.00 (1.00;1.00)
Abbreviations: p ≤ 0.05 in bold, OR odds ratio, CI confidence interval,
HRQoL Health-related quality of life, PA physical activity
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Table 5 Odds ratios and their 95 % confidence intervals as results from univariable and multivariable logistic regression analyses with session attendance and compliance with
the resistance and endurance exercises as dependent variables and demographic, clinical, psychosocial and physical variables as independent variables
HI LMI
Session attendance Compliance with the
resistance exercises
Compliance with the
endurance exercises
Session attendance Compliance with the
resistance exercises
Compliance with the
endurance exercises
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Univariable,
OR (95 % CI)
Multivariable,
OR (95 % CI)
Demographic
Age 1.01
(0.98;1.05)
1.00
(0.97;1.03)
1.01
(0.97;1.04)
1.00
(0.97;1.04)
1.03
(0.99;1.06)
1.01
(0.98;1.05)
Gender 0.62
(0.22;1.78)
0.51
(0.19;1.37)
0.97
(0.42;2.20)
0.71
(0.27;1.83)
0.45
(0.16;1.30)
0.41
(0.17;1.01)
Marital status 1.15
(0.44;3.04)
1.22
(0.49;3.02)
1.29
(0.54;3.07)
0.70
(0.23;2.14)
0.64
(0.19;2.16)
0.40
(0.14;1.20)
Education 1.29
(0.56;2.94)
1.84
(0.84;4.05)
1.67
(0.83;3.38)
0.66
(0.32;1.37)
0.49
(0.23;1.05)
0.45
(0.21;0.94)
Employment status 1.66
(0.75;3.66)
0.96
(0.45;2.03)
1.38
(0.69;2.78)
0.84
(0.41;1.75)
0.43
(0.19;0.94)
0.67
(0.33;1.35)
Smoking status 0.62
(0.14;2.64)
1.66
(0.33;8.42)
0.90
(0.23;3.52)
0.27
(0.06;1.19)
0.18
(0.03;0.97)
0.16
(0.03;0.91)
0.22
(0.03;1.87)
Sport history 1.61
(0.73;3.55)
0.95
(0.46;1.98)
1.22
(0.62;2.41)
1.40
(0.67;2.91)
1.54
(0.72;3.28)
0.92
(0.45;1.89)
Clinical
Cancer type 1.21
(0.52;2.81)
1.90
(0.83;4.35)
0.94
(0.46;1.93)
2.16
(0.97;4.80)
2.71
(1.16;6.36)
3.25
(1.31;8.02)
2.66
(1.27;5.56)
2.94
(1.38;6.27)
Stage of disease 1.39
(0.54;3.56)
1.73
(0.71;4.22)
0.77
(0.36;1.69)
0.82
(0.40;1.69)
0.85
(0.40;1.82)
1.30
(0.63;2.66)
Type of treatment
Radiation therapy 2.04
(0.92;4.54)
0.79
(0.38;1.65)
1.39
(0.71;2.76)
0.99
(0.49;2.04)
0.90
(0.43;1.88)
1.17
(0.58;2.37)
Immunotherapy 0.67
(0.25;1.82)
1.05
(0.40;2.79)
1.96
(0.78;4.91)
0.58
(0.26;1.28)
0.85
(0.37;1.93)
1.11
(0.50;2.44)
Hormone therapy 1.17
(0.53;2.58)
0.79
(0.38;1.64)
1.31
(0.67;2.59)
1.32
(0.64;2.72)
0.58
(0.28;1.23)
0.69
(0.34;1.41)
Comorbidities 0.68
(0.22;2.12)
0.66
(0.22;1.99)
0.73
(0.24;2.17)
0.63
(0.20;1.96)
0.75
(0.23;2.48)
1.62
(0.51;5.18)
BMI 0.93
(0.86;1.02)
0.99
(0.91;1.08)
0.94
(0.87;1.02)
1.05
(0.96;1.15)
1.10
(0.96;1.22)
1.11
(1.00;1.23)
1.09
(1.00;1.19)
1.11
(1.01;1.21)
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Table 5 Odds ratios and their 95 % confidence intervals as results from univariable and multivariable logistic regression analyses with session attendance and compliance with
the resistance and endurance exercises as dependent variables and demographic, clinical, psychosocial and physical variables as independent variables (Continued)
Psychosocial
General fatigue 0.92
(0.83;1.02)
0.92
(0.83;1.01)
0.97
(0.89;1.06)
1.00
(0.92;1.09)
1.03
(0.94;1.13)
1.05
(0.96;1.14)
Global HRQoL 1.01
(0.99;1.03)
1.02
(1.00;1.04)
1.01
(0.98;1.03)
1.00
(0.98;1.02)
1.00
(0.98;1.02)
1.01
(0.99;1.03)
Psychological
distress
0.93
(0.87;0.99)
0.87
(0.81;0.94)
0.87
(0.81;0.94)
0.91
(0.85;0.98)
1.00
(0.94;1.07)
1.01
(0.94;1.08)
1.00
(0.93;1.07)
Attitude 1.03
(1.01;1.04)
1.02
(1.01;1.04)
1.02
(1.00;1.04)
1.01
(0.99;1.03)
1.00
(0.98;1.02)
1.01
(0.99;1.03)
Perceived barriers 0.96
(0.92;0.99)
0.97
(0.94;1.00)
0.98
(0.95;1.01)
0.99
(0.96;1.02)
0.98
(0.95;1.01)
0.98
(0.95;1.01)
Outcome
expectations
1.01
(0.99;1.04)
1.00
(0.98;1.03)
1.01
(0.99;1.03)
1.00
(0.98;1.03)
1.02
(0.99;1.05)
1.00
(0.98;1.03)
Self-efficacy 1.06
(1.03;1.09)
1.06
(1.03;1.09)
1.02
(1.00;1.05)
1.05
(1.02;1.07)
1.05
(1.02;1.07)
1.00
(0.98;1.02)
1.00
(0.98;1.03)
1.01
(0.99;1.03)
Social support 1.00
(0.98;1.02)
1.00
(0.99;1.02)
1.00
(0.98;1.02)
1.00
(0.98;1.02)
1.00
(0.98;1.02)
1.01
(0.99;1.02)
Physical
Exercise stage 2.96
(1.26;6.93)
1.08
(0.52;2.26)
1.66
(0.83;3.33)
0.86
(0.42;1.77)
1.23
(0.58;2.60)
0.65
(0.32;1.32)
Self-reported PA 1.00
(0.99;1.01)
1.00
(1.00;1.01)
1.00
(1.00;1.01)
1.00
(0.99;1.00)
1.00
(0.99;1.00)
1.00
(1.00;1.00)
Environmental
Travel distance to
the exercise program
1.03
(0.96;1.11)
0.95
(0.89;1.03)
0.99
(0.92;1.06)
1.00
(0.94;1.07)
1.06
(0.99;1.15)
1.02
(0.96;1.08)
Abbreviations: p ≤ 0.05 in bold, OR odds ratio, CI confidence interval, HRQoL Health-related quality of life, BMI body mass index, PA physical activity
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endurance exercises did not differ significantly between
HI and LMI. This suggests that the exercise prescriptions
were equally feasible to perform when the participants
attended the session. Regarding exercise types, compli-
ance rates with resistance exercises were higher than
compliance rates with endurance exercises in both
groups. This may suggest that resistance exercises are
more feasible for cancer survivors than endurance exer-
cises. However, it may also reflect a lower accuracy of de-
fining the maximum workload by MSEC and HRR for the
endurance exercises, compared to the 1-RM measurement
for the resistance exercises. Although the steep ramp test
is a short maximal exercise capacity test, which has
proven to be a reliable and valid method to estimate car-
diorespiratory fitness in cancer survivors [31], its anaer-
obic nature may have overestimated the workload for the
endurance exercises. Comparably, the Karvonen formula
including HRR is a commonly used method to calculate
training workload for endurance exercises [32], however,
someone’s resting heart rate is prone to day-to-day
fluctuations.
Psychosocial variables were significantly associated with
high session attendance and high compliance with resist-
ance and endurance exercises in HI, but not in LMI. This
suggests that an individual’s self-efficacy and distress levels
are important characteristics while accomplishing a HI ex-
ercise program. Hence, including behavioral motivational
strategies aiming to improve these psychosocial variables
may support cancer survivors in achieving their exercise
goals, especially for participants with less favorable scores
in these variables to begin with. Participants with less fa-
vorable scores could also be recommended to start with
LMI exercise, and -after gaining further confidence in ex-
ercising- the exercise intensity could gradually increase
over time [33].
In LMI, only being a non-smoker or clinical factors were
significantly associated with high compliance with the re-
sistance or endurance exercises. Previous studies in non-
clinical populations have suggested that health-related
behaviors such as a physically active lifestyle and being a
non-smoker tend to cluster [34]. This may explain why
non-smokers had higher compliance rates. In contrast, the
significant association between higher BMI and high
compliance with resistance and endurance exercises seems
counterintuitive but may indicate that participants with a
lower BMI generally had better physical health and found
the training intensity of the LMI exercise program is less
challenging. A similar explanation could be suggested for
breast cancer survivors; LMI exercise might have been too
low for them compared to the other five cancer diagnosis
with generally lower 5-year survival rates, contributing to
lower compliance rates. Though, previous studies also
report that breast cancer survivors are more likely to ex-
perience difficulties in accomplishing resistance and
endurance exercises due to a limited range of motion in
the shoulders after surgery [35], cardiorespiratory prob-
lems after radiation therapy [36] or joint stiffness as a re-
sult of hormone therapy [37]. Yet, in our data we found
no significant associations between type of treatment
and exercise adherence. Future insight in the role of
cancer treatment in exercise adherence is warranted.
Strengths and limitations
To the best of our knowledge, the current study is the
first study assessing correlates of participation in exercise
after completion of primary cancer treatment, facilitated
by an extensive non-responder questionnaire completed by
179 non-participants. In addition, we assessed factors asso-
ciated with participants’ exercise adherence taking into
account both session attendance, as well as compliance to
the prescribed exercises. We included large sample sizes, a
relatively large number of potential demographic, clinical,
psychosocial and physical correlates, allowing multivariable
regression analyses. Yet, the following limitations should
be taken into account. First, 301 of our non-participants
(63 %) did not complete the extensive non-responder sur-
vey, which limits the generalizability of the current find-
ings. Nevertheless, no significant differences in age, gender
and cancer type were found between the participants of
the one-time survey and the non-responders. Second, the
discriminative ability of the models was moderate, ranging
from 0.62 to 0.75 [38]. This indicates that there may be
other variables that were not included in our study that are
important to explain differences in participation and adher-
ence rates among cancer survivors. For example, previous
research showed that low socioeconomic status was nega-
tively associated with adherence rates in cardiopulmonary
rehabilitation [39] and may warrant further investigation
among cancer survivors. Moreover, in general, studies that
have investigated social and environmental correlates of
participation and adherence rates among cancer survi-
vors are scarce. Previous studies in the healthy population
showed that social and environmental factors including
peer support, physician influence, and access to facilities
at flexible time points [40] were significantly associated
with exercise participation. Therefore, future studies should
examine whether social and environmental factors are
associated with participation in and exercise adherence
to an exercise program among cancer survivors. Finally,
theory-based interventions have shown to be more effective
in changing behavior than non-theory based interventions
[41]. Since the current study showed significant associations
of outcome expectations and self-efficacy with participation
in or adherence to an exercise program, forthcoming
studies might consider a role for behavioral theory such
as social cognitive theory or self-determination theory
[42], to facilitate a better understanding of exercise be-
havior in cancer survivors.
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Conclusion
This study showed that cancer survivors who attained a
higher level of education, were non-smokers, perceived
less psychological distress, had higher outcome expecta-
tions and perceived more exercise barriers were more
likely to participate in a combined resistance and endur-
ance exercise trial. This is worth acknowledging when
promoting exercise participation as part of usual cancer
care. Furthermore, the current study found several demo-
graphic, clinical and psychosocial factors to be significantly
associated with exercise adherence in which, psychosocial
factors, such as psychological distress and self-efficacy were
more strongly associated with HI than LMI exercise. When
offering HI exercise, it may therefore be recommended to
screen these variables, and if needed, include additional
behavioral motivational strategies or consider starting
at a lower training intensity.
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